rs374662467

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BP6

The NM_053025.4(MYLK):​c.5132C>T​(p.Thr1711Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,614,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1711R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

MYLK
NM_053025.4 missense

Scores

1
7
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 5.11

Publications

0 publications found
Variant links:
Genes affected
MYLK (HGNC:7590): (myosin light chain kinase) This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. [provided by RefSeq, Jul 2008]
MYLK-AS1 (HGNC:42440): (MYLK antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.38888866).
BP6
Variant 3-123626924-G-A is Benign according to our data. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734. Variant chr3-123626924-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 471734.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYLKNM_053025.4 linkc.5132C>T p.Thr1711Met missense_variant Exon 31 of 34 ENST00000360304.8 NP_444253.3 Q15746-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYLKENST00000360304.8 linkc.5132C>T p.Thr1711Met missense_variant Exon 31 of 34 5 NM_053025.4 ENSP00000353452.3 Q15746-1

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000318
AC:
8
AN:
251464
AF XY:
0.0000221
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000164
AC:
24
AN:
1461862
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
10
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111984
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41554
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jan 27, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MYLK: BP4 -

Aortic aneurysm, familial thoracic 7 Uncertain:1
Nov 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1711 of the MYLK protein (p.Thr1711Met). This variant is present in population databases (rs374662467, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with MYLK-related conditions. ClinVar contains an entry for this variant (Variation ID: 471734). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MYLK protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Dec 18, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.T1711M variant (also known as c.5132C>T), located in coding exon 28 of the MYLK gene, results from a C to T substitution at nucleotide position 5132. The threonine at codon 1711 is replaced by methionine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.041
T
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.31
.;.;.;T;.;T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.96
.;D;D;D;.;.
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.39
T;T;T;T;T;T
MetaSVM
Benign
-0.39
T
MutationAssessor
Benign
0.57
.;.;.;N;.;N
PhyloP100
5.1
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-2.9
D;.;D;D;D;D
REVEL
Benign
0.27
Sift
Uncertain
0.0070
D;.;D;D;D;D
Sift4G
Uncertain
0.016
D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;D
Vest4
0.54
MutPred
0.47
.;.;.;Gain of catalytic residue at T1711 (P = 0.0077);.;Gain of catalytic residue at T1711 (P = 0.0077);
MVP
0.93
MPC
0.86
ClinPred
0.61
D
GERP RS
5.2
Varity_R
0.18
gMVP
0.45
Mutation Taster
=62/38
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374662467; hg19: chr3-123345771; COSMIC: COSV100658669; COSMIC: COSV100658669; API